Chapter 66 - Attention Deficit Hyperactivity Disorder (ADHD) Flashcards

1
Q

ADHD Sx:

A
  • Inattention
  • Hyperactivity (dec with age)
  • Impulsivity

Patients usually have
- Difficulty focusing
- Are easily distracted
- Have trouble staying still
- Are frequently unable to control impulsive behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ADHD is caused by defect in:

Primary focus of ADHD research is on:

A
  • Defects in the dopamine pathways that regulate reward anticipation and emotional self-regulation
  • Primary focus of ADHD research is on the catecholamine system (dopamine is metabolized to epinephrine and norepinephrine).
  • They have very low dopamine levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment algorithm
- 1st line treatment based on age:
- 1st line medications
- 2nd line meds…

A

Pre-school aged children (age 4 - 5 years):
- Parent training in behavior management and/or behavioral classroom intervention.
- Methylphenidate can be considered if moderate-severe symptoms persist despite behavioral interventions.

> = 6 years old:
- 1st line: ADHD medications + behavioral interventions
————————————————–
1st line:
- Stimulant medications (e.g., methylphenidate and amphetamine) because they raise dopamine and norepinephrine levels.

  • Long-acting formulations are preferred for children
  • Atomoxetine (Strattera), a non-stimulant medication, can be tried when stimulants do not work well enough (after trials of 2 - 3 medications).
    Strattera can be used first line when prescribers are concerned about the possibility of abuse by the patient or family.
  • Guanfacine ER (Intuniv) and clonidine ER (Kapvay) are non-stimulant medications that can be used alone or in combination with stimulants.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis: Inattention

A

<=16 yo: >= 6 symptoms
>= 17 yo: >= 5 symptoms

  • For at least 6 months (1/2 a year) and are inappropriate for the developmental level.

Sx of inattention:
1- Fails to pay attention
2- Has trouble holding attention
3- Does not pay attention when someone is talking
4- Does not follow through on instructions
5- Fails to finish schoolwork
6- Has difficulty organizing tasks
7- Avoids/dislikes tasks which require mental effort
8- Loses things
9- Easily distracted and is forgetful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis: Hyperactivity & Impulsivity

A

<= 16 yo: >= 6 symptoms
>= 17 yo: >= 5 symptoms

  • Symptoms must have been present for at least 6 months and are inappropriate for the developmental level.

Sx of Hyperactivity and impulsivity:
1- Often fidgets or squirms
2- Leaves seat unexpectedly
3- Runs about when not appropriate
4- Unable to play quietly
5- Is “on the go” as if “driven by a motor,”
6- Talks excessively
7- Blurts out answers
8- Has trouble waiting his/her turn
9- Interrupts or intrudes on others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

THE FOLLOWING CONDITIONS MUST BE MET
for diagnosis:

A

1■ Several inattentive or hyperactive-impulsive symptoms were present before age 12.

2■ Symptoms must have been present in 2 or more settings (e.g.,at home, school, work, with friends or relatives, babysitters).

3■ Symptoms interfere with functioning and are not caused by another disorder.

We need either inattention or hyperactivity/impulsivity to diagnose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Natural Products:

A
  • Fish Oil modestly improve cognitive function
  • Melatonin is used to help with sleep onset in individuals taking stimulants.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Young children (and others) who cannot swallow capsules or tablets can use these long-acting formulations:

A

■ Capsule
- Some capsule contents can be sprinkled on a small amount of applesauce (Adderall XR, Ritalin LA)
- Vyvanse capsule contents can be mixed in water, orange juice or yogurt

■ Chewable tablet

■ Orally-disintegrating tablet

■ Patch

■ Suspension

  • When putting capsule contents in food, use a small amount of food and do not chew the beads.
  • Do not warm the food, and take it right away.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stimulants
- Are they first line or second line?
- When should you take them?
- List the different stimulants available.

A
  • 1st line
  • Take in AM

1- Methylphenidate (e.g., Concerta, Daytrana, Ritalin)
(meth fen? date - contert - date rana - rita lin)

2- Lisdexamfetamine (Vyvanse)

3- Dextroamphetamine/Amphetamine (Adderall, Adderall XR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-stimulants
- Are they first line or second line?
- List the non-stimulant drugs

A
  • Second line (if 2-3 stimulants are used)
  • Take if risk of abuse (1st line)
  • Atomoxetine (Strattera)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Add-on medications (or used alone)
Name them + their brand names

A
  • Guanfacine ER (Intuniv) (guana is in-tounis)
  • Clonidine ER (Kapvay)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

To help sleep at night

A
  • Clonidine IR (Catapres) (note: not the ER!)
  • Diphenhydramine (OTC 25-50 mg) (Antihistamine H1 antagonist)
  • Melatonin (OTC 2-5 mg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Methylphenidate
IR Tablet brand
Dose
Max dose

A

Ritalin
Start 5 mg BID, 30 min before breakfast and lunch
Max: 60 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Methylphenidate
IR oral solution

A

Methylin
Start 5 mg BID, 30 min before breakfast and lunch
Max: 60 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methylphenidate
- ER Tablet
- Dose + Max dose
- In what conditions should you not use it?
- How does OROS work?
- Does it have a high abuse potential?

A

Concerta OROS (or2os bl concert)

Dose: Start 18-36 mg QAM (Max: 72 mg/day)

Warning:
Do not use with GI narrowing conditions (e.g., motility issues, small bowel disease) (Mafiyun yruho aal concert)

  • The outer coat dissolves fast to give immediate action, and the rest is released slowly;
  • Can see a ghost tablet in stool; (Marra b tiz l zamen mn ruh aa concert)
  • Harder to crush which decreases abuse potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Methylphenidate
ER Capsule

A

Ritalin LA:
Dose: start 10-20 mg QAM

Jornay PM:
- Dose: start 20 mg QPM (the journey starts at night)
- Max dose: 100 mg/day

  • Outer coating delays initial drug release 10 hours to allow for evening dosing
  • Inner coating controls the slow release of the drug during the day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Methylphenidate
Transdermal patch

How do you apply it?
Warnings?

A

Daytrana (date rana cz hiye laz2a)

Dose: Start 10 mg/9 hr patch QAM
Max: 30 mg/9 hr

  • Apply 2 hrs before desired effect (or as soon as the child awakens so it starts to deliver prior to school);
  • Remove after 9 hrs;
  • Alternate hips daily

Warning:
- Loss of skin pigmentation at application site and areas distant from the application site (can resemble vitiligo);

  • Allergic contact dermatitis with local reactions (e.g.,edema, papules)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Methylphenidate
ER chewable tablet:

A

QuilliChew ER
Chewable tablets: contain phenylalanine (avoid with PKU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

SE of methylphenidate

A
  • Insomnia
  • Dec appetite/weight loss
  • Nausea/ Vomiting
  • Blurry vision
  • Dry mouth
  • Headache
  • Irritability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Monitoring with methylphenidate

A
  • Consider ECG prior to treatment
  • Monitor BP and HR
  • Cardiac symptoms
  • CNS effects
  • Abuse potential
  • Height and weight (children)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dexmethylphenidate
- Brands
- How can u convert from methylphenidate to dexmethylphenidate?

A
  • Focalin (IR tablet)
  • Focalin XR (ER Capsule)
    (dexter took meth phen? date so foc Aline)
  • Active isomer of methylphenidate;
  • To convert from methylphenidate to dexmethylphenidate use one-half of the total daily dose of methylphenidate (dexmeth is stronger so we need half dose) (dexter needs half dose cz foc aline)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Serdexmethylphenidate

A
  • Prodrug to dexmethylphenidate
  • Provides extended duration of action following faster-acting dexmethylphenidate
    (la ser de dexter hiye prodrug w aanda loger DOA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Dextroamphetamine/Amphetamine

A

IR tablet: Adderall

ER capsules: Adderall XR, Mydayis (mid days like adderall)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Amphetamine

A
  • ER orally-disintegrating tablet: Adzenys XR-ODT
  • ER oral suspensions: Dyanavel XR, Adzenys ER
  • IR tablet: Evekeo
  • IR orally-disintegrating tablet: Evekeo ODT

(Amphetamine is l asliyye so Eve & Adzam shab so ER w ejit diana threesome maaun kamen ER so hiye ekhde dor l shab)

25
Q

Dextroamphetamine

A
  • ER capsule: Dexedrine (w ER Dex sandrine)
  • IR oral solution: ProCentra (Doghre (IR) rahet aa a PRO centre teshrab)
  • IR tablet: Zenzedi (zen l atet aamel IR tablet)
26
Q

BBW with Amphetamine, Dextroamphetamine, and combination

A

Misuse can cause sudden death and serious CV events

27
Q

Warning with Adzenys ER:

A

Amphetamine Oral Suspension ER:
Risk of intestinal necrosis when used with:
- Sodium polystyrene sulfonate
- Sorbitol
(SPS-S)

28
Q

What products are approved for Children >= 3 years old

A

IR products except Evekeo ODT (Eve IR l ODT ma bt ti2 l wled)

29
Q

AAP guidelines do not recommend What drugs in pts of what age?

A

<= 5 yo
Dextroamphetamine

30
Q

Can ER formulations be substituted for other amphetamine products on a mg-per-mg bases?

A

ER formulations cannot be substituted for other amphetamine products on a mg-per-mg basis,
follow dosing schedule provided by manufacturer

31
Q

Conversion from Adderall XR capsule to Adzenys ER (oral suspension) or XR-ODT:

if the pt is taking 10 mg of Adderall XR, what dose of Adzenys ER should you give?

A

Use 3.1 mg of Adzenys ER or XR-ODT for each 5 mg dose of Adderall XR

  • 6.2 mg
32
Q

Counseling with amphetamines and dextroamph

A

Do not take with acidic foods such as juice or vitamin C (dec absorption)

33
Q

Lisdexamfetamine
- Brand
- Dosage forms
- Dose + Max dose
- Advantage?

A
  • Vyvanse
  • Capsule, chewable tablet

Start
- 20-30 mg QAM (children)
- 30 mg QAM (adults)
Max: 70 mg/day

  • Low abuse potential; prodrug composed of I-lysine (amino acid) bonded to dextroamphetamine
  • It is hydrolyzed in the blood to active dextroamphetamine
  • If injected or snorted, the fast effect (rush) is muted
34
Q

Methamphetamine
- Brand
- Dose + Max dose

A
  • Desoxyn
  • Tablet
  • Start 5 mg QAM or BID
  • Max: 20-25 mg daily
35
Q

Are non-stimulants 1st or 2nd line?

A
  • Used second line after trials of stimulant medications have failed.
  • They can be used first line if the prescriber is concerned about abuse potential.
36
Q

Are non-stimulants controlled meds?

A

Non-stimulant medications for ADHD are not controlled and therefore do not have the same potential for abuse and dependence as stimulants.

37
Q

What antihypertensive drugs are used as non-stimulants for ADHD? How are they marketed?

A
  • Clonidine and guanfacine
  • Are marketed in longer-acting formulations for ADHD
  • Clonidine IR can still be used to help with sleep
38
Q

For what is Viloxazine FDA approved?
What is its brand name?
MOA?

A

Viloxazine (Qelbree) (Villa luxe zine - quelle brie - lal peds 6 - 17 yo)

  • SNRI
  • New selective norepinephrine reuptake inhibitor FDA-approved for ADHD treatment in pediatric patients 6-17 years of age.

(Desoxyn –> Methamphetamine)
(Qelbree –> Viloxazine)

39
Q

Atomoxetine
- MOA
- Brand
- Dosage form
- Max Dose
- DDI

A
  • Selective Norepinephrine Reuptake Inhibitor (SNRI)
  • Strattera
  • Capsule

> 70 kg: start 40 mg daily
<= 70 kg: start 0.5 mg/kg/day
Max: 100 mg/day
Can take in divided doses if needed (morning and late afternoon/early evening)

  • Strong CYP450 2D6 inhibitors (e.g.,paroxetine): max is 80 mg daily
40
Q

BBW of Atomoxetine

A

Risk of suicidal ideation;
- Monitor for suicidal thinking or behavior
- Worsening mood
- Unusual behavior

(Ato mot = suicide)

41
Q

CI with Strattera

A
  • MAO inhibitor use within the past 14 days
  • Glaucoma
  • Pheochromocytoma
  • Severe cardiovascular disorders

The use of most CNS stimulants is contraindicated in patients with glaucoma, as these agents exhibit sympathomimetic activity and may induce mydriasis provoking an increase in intraocular pressure.
Serious reactions, including elevated blood pressure and tachyarrhythmia, have been reported in patients with pheochromocytoma or a history of pheochromocytoma who received STRATTERA

42
Q

Warnings with atomoxetine

A
  • Aggressive behavior
  • Treatment-emergent psychotic or manic symptoms
  • Orthostasis and syncope
  • Allergic reactions
  • Priapism
  • Urine hesitancy and retention
  • Rare but severe hepatotoxicity (most often within 120 days of starting treatment)
  • Serious cardiovascular events; assess at baseline and as needed during treatment and avoid use if known cardiac disease
  • Projected height and weight can be reduced in children
43
Q

SE with atomoxetine

A
  • Dec appetite
  • Insomnia
  • Somnolence
  • Dry mouth
  • Hypertension
  • Tachycardia
  • Headache
  • Nausea
  • Abdominal pain
  • Erectile dysfunction
  • Dec libido
44
Q

Monitoring with Atomoxetine

A
  • BP
  • HR
  • ECG
  • Mood
  • Height and weight (children)
45
Q

Can you open the capsule of atomoxetine

A

NO! Ocular irritant

(you cant open an atom - byujaauke 3yunik)

46
Q

Clonidine ER
- MOA
- Brand
- Dose

A
  • Central Alpha-2A Adrenergic Receptor Agonists
  • Kapvay Tablet

Dose:
- Start 0.1 mg QHS
- Max 0.4 mg/d
- Take BID; if uneven dosing take the higher dose QHS

47
Q

Clonidine IR

A

Catapres - for hypertension

48
Q

Guanfacine ER
- MOA
- Brand
- Dose
- What increases its absorption? Should you or should you not take it?

A
  • Central Alpha-2A Adrenergic Receptor Agonists
  • lntuniv
  • Dose: Start 1 mg daily and increase by <= 1 mg weekly
  • Do not take with high-fat meal (inc absorption)
49
Q

Guanfacine IR tablet

A

Tenex - for hypertension

50
Q

Warning with Central Alpha-2A Adrenergic Receptor Agonists

A
  • Dose-dependent cardiovascular effects (bradycardia, hypotension, orthostasis, syncope), sedation and drowsiness
  • Do not discontinue abruptly (can cause rebound hypertension)
  • Guanfacine: skin rash (rare, discontinue if occurs);
  • Dose adjustments required with CYP3A4 inducers and inhibitors
51
Q

SE with Central Alpha-2A Adrenergic Receptor Agonists
What should you monitor?

A
  • Dry mouth
  • Somnolence
  • Fatigue
  • Dizziness
  • Constipation
  • Dec HR
  • Hypotension
  • Headache
  • Nausea
  • Abdominal pain

BP,HR

(atomoxetine (SNRI) inc BP & HR)
(alpha 2 agonists dec BP & HR)

52
Q

Why should you taper off clonoidine and guanficine?

Can u substitue IR clonidine or guanficine for ER?

A

Must be tapered off to decrease the risk of REBOUND HYPERTENSION:
- Decrease dose (<= 0.1 mg/day for clonidine and <= 1 mg/day for guanfacine) every 3-7 days

Do not substitute IR clonidine or guanfacine for ER formulations

53
Q

Atomoxetine Drug Interactions

A
  • Atomoxetine is a CYP2D6 substrate
  • CYP2D6 inducers or inhibitors can necessitate a change in atomoxetine dose.

Strong CYP450 2D6 inhibitors (e.g.,paroxetine): max is lowered to 80 mg daily instead of 100.

54
Q

Clonidine and Guanfacine Drug Interactions

A
  • Watch for additive sedation when used in combination with other CNS depressants.
  • Use caution with other drugs that decrease blood pressure and heart rate (beta-blockers, non-DHP CCBs).

Guanfacine:
- Double the dose if used with strong CYP3A4 inducers.
- Decrease the dose by 50% if used with strong CYP3A4 inhibitors.

55
Q

STIMULANT SAFETY CONCERNS

A
  • All stimulants are C-II medications and must be dispensed with a MedGuide.
  • The Boxed Warnings, Contraindications and Warnings discussed on this page are common to most stimulant drugs and will not be repeated in the stimulant drug tables that follow.
56
Q

Boxed Warnings of all stimulants

A
  • Stimulant medications have a high potential for abuse and dependence.
  • Risk for abuse (e.g., history of alcohol or drug abuse) should be assessed prior to dispensing.
  • Symptoms of abuse (e.g., dilated pupils, increased heart rate and blood pressure, sweating, tremor, anxiety) should be monitored during treatment.
  • When abused long-term, tolerance and psychological dependence can occur, with varying degrees of abnormal behavior (including psychotic episodes when injected).
  • When withdrawing treatment from someone abusing a stimulant, severe depression can occur.
57
Q

CI with stimulants

A

■ Do not use within 14 days of an MAO inhibitor due to the risk of hypertensive crisis when used together.

■ Due to the risk of cardiovascular events, some stimulants are contraindicated with comorbid heart failure, recent myocardial infarction, arrhythmias or moderate-severe hypertension.

■ Most stimulants are contraindicated in patients with marked anxiety, tension, agitation, glaucoma, hyperthyroidism, or a history of Tourette’s syndrome or other tic disorders.

58
Q

Warnings

A

■ Cardiac Function:
- Increased levels of dopamine and norepinephrine can increase heart rate and blood pressure.
- This can cause serious cardiovascular events in children and adults with or without preexisting cardiac disease.
- Assess for cardiac disease at baseline and avoid stimulants when cardiac abnormalities are present, due to an increased risk of sudden death.

■ Other vascular problems (Priapism, Raynaud’s disease) can occur and may require dose reduction or discontinuation.

■ Psychiatric Conditions:
- New-onset psychosis or mania, or an exacerbation of preexisting psychosis (mixed/manic episode in bipolar disorder) can occur.
- Caution should be used when prescribing stimulants in patients with a preexisting psychiatric condition.

■ Seizures:
- Some stimulants can lower the seizure threshold, which increases the risk for seizures.

■ A loss of appetite is common.
This is especially concerning in children, as it can contribute to a decrease in the child’s growth trajectory.

■ Serotonine Syndrome:
- The risk of serotonin syndrome is increased when stimulants are used in combination with other serotonergic drugs (e.g., SSRis, SNRis, TCAs, buspirone).

■ Visual disturbances
- Difficulty with accommodation and blurry vision

59
Q

Counseling

A

STIMULANTS
■ MedGuide required.
■ Can cause:
- Increased heart rate and blood pressure
- Serious cardiovascular events
- Insomnia
- Psychosis
- Priapism
■ Decreased appetite: eat a larger breakfast to prevent weight loss; check height and weight regularly in children.
■ Ghost tablet in stool (Concerta).
■ Some formulations contain phenylalanine. Do not use if you have phenylketonuria

ATOMOXETINE
■ MedGuide required.
■ Can cause:
- Liver damage
- Suicidal ideation
- Somnolence